Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
260
NCT00954252
Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2009
Completion: May 31, 2010
NCT01203384
Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male Subjects
Start: Sep 30, 2010
Completion: Dec 31, 2010
NCT01258452
Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects
Start: Feb 28, 2011
Completion: Mar 31, 2011
NCT01303744
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074
Phase: Phase 2
Start: Mar 31, 2011
Completion: Apr 30, 2012
NCT01723670
Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment
Start: Dec 31, 2012
Completion: Mar 31, 2016
NCT07051590
Adjustment Period for Partial Crowns
Phase: N/A
Start: Aug 20, 2025
Completion: Jan 20, 2027